Amendment: SEC Form SC 13G/A filed by ICU Medical Inc.

11/12/24 3:44:43 PM ET

Medical/Dental Instruments

Health Care

Get the next $ICUI alert in real time by email

SC 13G/A 1 r13ga1-icu20240930.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Amendment No. 1) Under the Securities Exchange Act of 1934 ICU Medical, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 44930G107 (CUSIP Number) September 30, 2024 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) For IA & IAR [ ] Rule 13d-1(c) For LP if any [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out or a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 44930G107 SCHEDULE 13G Page 2 of 5 1 Name of Reporting Person Fuller & Thaler Asset Management, Inc. IRS Identification No. of Above Person 94-3176968 2 Check the Appropriate Box if a Member of a Group (a) [ ] (b) [ ] 3 SEC USE ONLY 4 Citizenship or Place of Organization California 5 Sole Voting Power 1,390,673 NUMBER OF 6 Shared Voting Power SHARES BENEFICIALLY -0- OWNED BY EACH REPORTING 7 Sole Dispositive Power PERSON WITH 1,412,644 8 Shared Dispositive Power -0- 9 Aggregate Amount Beneficially Owned by each Reporting Person 1,412,644 10 Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares* [ ] 11 Percent of Class Represented by Amount in Row 9 5.78% 12 Type of Reporting Person* IA CUSIP No. 44930G107 SCHEDULE 13G Page 3 of 5 Item 1(a). Name of Issuer. ICU Medical, Inc. Item 1(b). Address of Issuer's Principal Executive Offices. 951 Calle Amanecer San Clemente, CA 92763-6212 Item 2(a). Names of Persons Filing. Fuller & Thaler Asset Management, Inc. Item 2(b). Address of Principal Business Office or, if none, Residence. 411 Borel Avenue, Suite 300, San Mateo, CA 94402. Item 2(c). Citizenship. California corporation. Item 2(d). Title of Class of Securities. Common Stock Item 2(e). CUSIP Number. 44930G107 Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) [ ] Investment company registered under section 8 of the Investment Company act of 1940 (15 U.S.C. 80a-8). CUSIP No. 44930G107 SCHEDULE 13G Page 4 of 5 (e) [X] An investment adviser in accordance with 240.13d- 1(b)(1)(ii)(E). (f) [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F). (g) [ ] A parent holding company or control person in accordance with 240.13b-1(b)(1)(ii)(G). (h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813). (i) [ ] A church plan that is excluded form the definition of an investment company under section 3(c)(14) of the Investment Company act of 1940 (15 U.S.C. 80a-3). (j) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(J). Item 4. Ownership. Reference is made hereby to Items 5-9 and 11 of Page two (2) of this Schedule 13G, which Items are incorporated by reference herein. Item 5. Ownership of Five Percent or Less of a Class. Not applicable. Item 6. Ownership of More Than Five Percent on Behalf of Another Person. Fuller & Thaler Asset Management, Inc. is deemed to be the beneficial owner of the number of securities reflected in Items 5-9 and 11 of page two (2) of this Schedule 13G pursuant to separate arrangements whereby it acts as investment adviser to certain persons. Each person for whom Fuller & Thaler Asset Management, Inc. acts as investment adviser has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Common Stock. Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company. Not applicable. CUSIP No. 44930G107 SCHEDULE 13G Page 5 of 5 Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certification. By signing below, Fuller & Thaler Asset Management, Inc. certifies that, to the best of its knowledge and belief, the securities referred to above on page two (2) of this Schedule 13G were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. DATED: November 8, 2024 Fuller & Thaler Asset Management, Inc. /s/ Hanna Zanoni ________________________ By: Hanna Zanoni its: Chief Compliance Officer

Get the next $ICUI alert in real time by email

Recent Analyst Ratings for

$ICUI

Date	Price Target	Rating	Analyst
8/15/2025	$145.00	Overweight	Piper Sandler
3/12/2025	$205.00 → $197.00	Outperform → Strong Buy	Raymond James
12/11/2024	$200.00	Hold → Buy	Jefferies
10/14/2024	$183.00	Hold	Jefferies
6/21/2024		Hold	Needham
6/17/2024	$135.00	Mkt Perform → Outperform	Raymond James
11/8/2022		Outperform → Mkt Perform	Raymond James
2/28/2022	$286.00 → $265.00	Outperform	Raymond James

More analyst ratings

Amendment: SEC Form SC 13G/A filed by ICU Medical Inc.

11/12/24 3:44:43 PM ET

$ICUI

Medical/Dental Instruments

Health Care

Get the next $ICUI alert in real time by email

Recent Analyst Ratings for

$ICUI

Date	Price Target	Rating	Analyst
8/15/2025	$145.00	Overweight	Piper Sandler
3/12/2025	$205.00 → $197.00	Outperform → Strong Buy	Raymond James
12/11/2024	$200.00	Hold → Buy	Jefferies
10/14/2024	$183.00	Hold	Jefferies
6/21/2024		Hold	Needham
6/17/2024	$135.00	Mkt Perform → Outperform	Raymond James
11/8/2022		Outperform → Mkt Perform	Raymond James
2/28/2022	$286.00 → $265.00	Outperform	Raymond James

More analyst ratings

Amendment: SEC Form SC 13G/A filed by ICU Medical Inc.

Crush Q3 2025 with the Best AI Superconnector

Recent Analyst Ratings for
$ICUI

Amendment: SEC Form SC 13G/A filed by ICU Medical Inc.

Crush Q3 2025 with the Best AI Superconnector

Recent Analyst Ratings for
$ICUI

$ICUI
FDA approvals

FDA Approval for POTASSIUM CHLORIDE 0.149% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER issued to ICU MEDICAL INC

$ICUI
Press Releases

ICU Medical to Participate in Upcoming Investor Conferences

ICU Medical Announces Second Quarter 2025 Results and Updates its Fiscal Year 2025 Guidance

ICU Medical Announces Time of Second Quarter 2025 Earnings Conference Call

$ICUI
Insider Purchases

Chairman and CEO Jain Vivek bought $2,474,375 worth of shares (21,929 units at $112.84), increasing direct ownership by 20% to 130,149 units (SEC Form 4)

$ICUI
Insider Trading

Chairman and CEO Jain Vivek bought $2,474,375 worth of shares (21,929 units at $112.84), increasing direct ownership by 20% to 130,149 units (SEC Form 4)

VP, General Counsel Sanzone Virginia Ruth sold $93,537 worth of shares (700 units at $133.62), decreasing direct ownership by 10% to 6,386 units (SEC Form 4)

Chief Operating Officer Voigtlander Christian B. exercised 11,115 shares at a strike of $96.83 and sold $1,288,371 worth of shares (9,930 units at $129.75), increasing direct ownership by 24% to 6,088 units (SEC Form 4)

$ICUI
SEC Filings

SEC Form S-8 filed by ICU Medical Inc.

SEC Form 10-Q filed by ICU Medical Inc.

ICU Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

$ICUI
Analyst Ratings

Piper Sandler initiated coverage on ICU Medical with a new price target

ICU Medical upgraded by Raymond James with a new price target

ICU Medical upgraded by Jefferies with a new price target

$ICUI
Financials

ICU Medical Announces Second Quarter 2025 Results and Updates its Fiscal Year 2025 Guidance

ICU Medical Announces Time of Second Quarter 2025 Earnings Conference Call

ICU Medical Announces First Quarter 2025 Results

$ICUI
Large Ownership Changes